Press Releases

SAN CARLOS, Calif., Dec. 18, 2019 /PRNewswire/ -- IncellDx, Inc. and Biolidics have announced today that they have signed a Distribution Agreement for the IncellDx bioINK® PD-L1 CTC Core Kit. Biolidics will distribute  the product with the Biolidics' ClearCell® FX1 System.The IncellDx bioINK® PD-L1 Core Kit is pre-optimized to ena

Read more...

CHICAGO, Dec. 18, 2019 /PRNewswire/ -- The National Council of State Boards of Nursing Board of Directors (NCSBN BOD) voted on Dec. 9, 2019, to raise the passing standard for the NCLEX-PN Examination (the National Council Licensure Examination for Practical Nurses).  The new passing standard is -0.18 logits, 0.03 logits higher

Read more...

WASHINGTON, Dec. 18, 2019 /PRNewswire/ -- The Community Oncology Alliance (COA) is pleased to announce the election of new and re-appointed members to the Board of

Read more...

NEWPORT NEWS, Va., Dec. 18, 2019 /PRNewswire/ -- Orthopaedic and Spine Center announced Dr. Jeffrey Carlson, Orthopaedic Spine Surgeon, became the first surgeon in Central and Eastern Virginia area to implant the M6-C™ artificial cervical disc.  The outpatient surgery was perform

Read more...

INDIANAPOLIS, Dec. 18, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today the launch of TRIUMPH, a long-term, real-world evidence study of Emgality® (galcanezumab-gnlm). The objective of the TRIUMPH study (Preventive Treatment of Migraine: Outcomes for

Read more...

DENVER, Dec. 18, 2019 /PRNewswire/ -- DaVita Kidney Care today announced Dr. Jeffrey Giullian as chief medical office

Read more...

MINNEAPOLIS, Dec. 18, 2019 /PRNewswire/ -- Conventus Orthopaedics, Inc., a medical device company dedicated to revolutionizing fracture treatment, today announced that it has acquired all  assets of IntraFuse, LLC.  IntraFuse has developed proprietary intramedullary implants for the minimally invasive repair of fractures, including fibula fractures. This a

Read more...

SOUTH SAN FRANCISCO, Calif., Dec. 18, 2019 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, announced the appointment of Wendy L. Yarno as a Director of its Board of Directors.  

Read more...

WALTHAM, Mass., Dec. 18, 2019 /PRNewswire/ -- Extending its footprint in the Northeast, 42 North Dental has completed an affiliation with Browne, Goetz & Miraglia (BGM) (bgmdental.com), a premiere dental practice in Mount Kisco, NY. The practice, located in Westchester County, is led by Dr.

Read more...

TAIPEI, Taiwan, Dec. 18, 2019 /PRNewswire/ -- OBI Pharma, a Taiwan biopharma company (TPEx: 4174), today announced the initiation of a Phase 1/2 clinical trial (ClinicalTrials.gov Identifier: NCT04084366) of OBI-999, an antibody drug conjugate (ADC) targeting Globo H, a glycolipid antigen overexpressed in multiple tumor types. Patients wi

Read more...